Iterum Therapeutics plc (NASDAQ: ITRM)
$1.30
-0.2800 ( -17.70% ) 599.2K
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Market Data
Open
$1.30
Previous close
$1.58
Volume
599.2K
Market cap
$22.27M
Day range
$1.29 - $1.64
52 week range
$0.62 - $2.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 04, 2023 |
pre | Proxies and info statements | 4 | Dec 04, 2023 |
4 | Insider transactions | 1 | Nov 27, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
10-q | Quarterly Reports | 90 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
8-k | 8K-related | 13 | Oct 24, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
8-k | 8K-related | 12 | Oct 02, 2023 |